Almanack Investment Partners, Llc. Regeneron Pharmaceuticals, Inc. Transaction History

Almanack Investment Partners, Llc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$883.2 - $1071.19 $2.65 Million - $3.21 Million	-2,996 Reduced 55.41%	2,411 $2.53 Million
Q1 2024 May 01, 2024	BUY	$902.69 - $993.35 $2.53 Million - $2.79 Million	2,807 Added 107.96%	5,407 $5.2 Million
Q4 2023 Feb 07, 2024	SELL	$775.18 - $881.7 $2.95 Million - $3.35 Million	-3,800 Reduced 59.38%	2,600 $2.28 Million
Q3 2023 Oct 05, 2023	SELL	$692.45 - $844.37 $553,960 - $675,496	-800 Reduced 11.11%	6,400 $5.27 Million
Q2 2023 Aug 07, 2023	BUY	$700.03 - $830.35 $1.54 Million - $1.83 Million	2,200 Added 44.0%	7,200 $5.17 Million
Q1 2023 May 08, 2023	SELL	$680.49 - $826.97 $4.29 Million - $5.21 Million	-6,300 Reduced 55.75%	5,000 $4.11 Million
Q4 2022 Feb 08, 2023	BUY	$705.89 - $766.39 $7.98 Million - $8.66 Million	11,300 New	11,300 $8.15 Million

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Almanack Investment Partners, Llc., based on Form 13F filings with the SEC.

Stay updated on Almanack Investment Partners, Llc. with notifications on news.